Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach P Sarogni, MM Pallotta, A Musio Journal of medical genetics 57 (5), 289-295, 2020 | 74 | 2020 |
Pathogenic variants in EP300 and ANKRD11 in patients with phenotypes overlapping Cornelia de Lange syndrome F Cucco, P Sarogni, S Rossato, M Alpa, A Patimo, A Latorre, C Magnani, ... American Journal of Medical Genetics Part A 182 (7), 1690-1696, 2020 | 41 | 2020 |
Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development P Sarogni, O Palumbo, A Servadio, S Astigiano, B D’Alessio, V Gatti, ... Journal of Experimental & Clinical Cancer Research 38, 1-16, 2019 | 40 | 2019 |
Tumor grafted–chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation AK Mapanao, PP Che, P Sarogni, P Sminia, E Giovannetti, V Voliani Expert Opinion on Drug Metabolism & Toxicology 17 (8), 947-968, 2021 | 35 | 2021 |
Targeting heparan sulfate proteoglycans as a novel therapeutic strategy for mucopolysaccharidoses V De Pasquale, P Sarogni, V Pistorio, G Cerulo, S Paladino, LM Pavone Molecular Therapy Methods & Clinical Development 10, 8-16, 2018 | 31 | 2018 |
Antioxidant treatment ameliorates phenotypic features of SMC1A-mutated Cornelia de Lange syndrome in vitro and in vivo D Cukrov, TAC Newman, M Leask, B Leeke, P Sarogni, A Patimo, ... Human molecular genetics 27 (17), 3002-3011, 2018 | 31 | 2018 |
EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB V De Pasquale, A Pezone, P Sarogni, A Tramontano, GG Schiattarella, ... Cell death & disease 9 (2), 40, 2018 | 27 | 2018 |
Chorioallantoic membrane tumor models highlight the effects of cisplatin compounds in oral carcinoma treatment P Sarogni, AK Mapanao, A Gonnelli, ML Ermini, S Marchetti, C Kusmic, ... IScience 25 (3), 2022 | 19 | 2022 |
Chromosome missegregation in single human oocytes is related to the age and gene expression profile S Barone, P Sarogni, R Valli, MM Pallotta, G Silvia, A Frattini, AW Khan, ... International Journal of Molecular Sciences 21 (6), 1934, 2020 | 17 | 2020 |
Curcumin and graphene oxide incorporated into alginate hydrogels as versatile devices for the local treatment of squamous cell carcinoma LF Madeo, P Sarogni, G Cirillo, O Vittorio, V Voliani, M Curcio, T Shai-Hee, ... Materials 15 (5), 1648, 2022 | 13 | 2022 |
Pro-apoptotic and size-reducing effects of protein corona-modulating nano-architectures enclosing platinum prodrug in in vivo oral carcinoma AK Mapanao, P Sarogni, M Santi, M Menicagli, A Gonnelli, A Zamborlin, ... Biomaterials Science 10 (21), 6135-6145, 2022 | 13 | 2022 |
A Standard Protocol for the Production and Bioevaluation of Ethical In Vivo Models of HPV-Negative Head and Neck Squamous Cell Carcinoma P Sarogni, AK Mapanao, S Marchetti, C Kusmic, V Voliani ACS Pharmacology & Translational Science 4 (3), 1227-1234, 2021 | 11 | 2021 |
Hybrid nano-architectures loaded with metal complexes for the co-chemotherapy of head and neck carcinomas M Santi, V Frusca, ML Ermini, AK Mapanao, P Sarogni, A Gonnelli, ... Journal of Materials Chemistry B 11 (2), 325-334, 2023 | 9 | 2023 |
Disease-associated c-MYC downregulation in human disorders of transcriptional regulation MM Pallotta, M Di Nardo, P Sarogni, ID Krantz, A Musio Human Molecular Genetics 31 (10), 1599-1609, 2022 | 9 | 2022 |
A bioconvergence study on platinum-free concurrent chemoradiotherapy for the treatment of HPV-negative head and neck carcinoma A Gonnelli, P Sarogni, N Giannini, S Linsalata, F Di Martino, A Zamborlin, ... Artificial Cells, Nanomedicine, and Biotechnology 52 (1), 122-129, 2024 | 3 | 2024 |
Drug-Free Hybrid Nanoarchitecture Modulation of the Metastatic Behavior of Pancreatic Ductal Adenocarcinoma in Alternative in Vivo Models A Zamborlin, P Sarogni, V Frusca, A Gonnelli, N Giannini, ML Ermini, ... ACS Applied Nano Materials 6 (24), 22532-22544, 2023 | 3 | 2023 |
Hyperthermia Reduces Irradiation‐Induced Tumor Repopulation in an In Vivo Pancreatic Carcinoma Model P Sarogni, A Zamborlin, AK Mapanao, T Logghe, L Brancato, E van Zwol, ... Advanced Biology 7 (10), 2200229, 2023 | 2 | 2023 |
Non‐Persistent Nano‐Architectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma A Gonnelli, MG de Thoré, ML Ermini, V Frusca, A Zamborlin, N Signolle, ... Advanced Materials, 2400949, 2024 | | 2024 |
Tumor growth-arrest effect of tetrahydroquinazoline-derivative human topoisomerase II-alpha inhibitor in HPV-negative head and neck squamous cell carcinoma P Sarogni, N Brindani, A Zamborlin, A Gonnelli, M Menicagli, ... Scientific Reports 14 (1), 9150, 2024 | | 2024 |